Klaus Schuster

Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.

A. deFazio, M. Friedlander, C. Pang, 2018, Gynecologic oncology.

Preventive, predictive, and personalized medicine for effective and affordable cancer care

J. Janssens, A. Voss, Klaus Schuster, 2018, EPMA Journal.

Preventive, predictive, and personalized medicine for effective and affordable cancer care

J. Janssens, A. Voss, Klaus Schuster, 2018, EPMA Journal.

Durable Response to Vismodegib in PTCH1 F1147fs Mutant Relapsed Malignant Pleural Mesothelioma: Implications for Mesothelioma Drug Treatment

A. Nicholson, D. Fennell, B. Sharma, 2021 .

Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatment

U. Siebert, G. Spizzo, R. Leonard, 2019, Cost Effectiveness and Resource Allocation.